9939 — Kintor Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$750.48m
- HK$870.57m
- CNY32.68m
Brief: Kintor Pharmaceutical Says It Will To Lend HK$116.9 Mln To CEO
Brief: Kintor Pharmaceutical Says Yan Lu Appointed Executive Director
Brief: Kintor Pharma Announced Successful Dosing Of First Patient For Acne Vulgaris
HK stocks end firmer tracking China as authorities vow to support growth
Kintor plummets after unsatisfactory interim analysis on COVID-19 pill trial (updated)
China's Kintor hits record low as COVID treatment trial misses statistical criteria
China's Kintor says interim analysis of COVID treatment trial misses statistical criteria (updated)
China's Kintor says Phase III COVID-19 treatment trial misses statistical criteria
Brief: Kintor Pharmaceutical Says Investigational New Drug Application For Study Of Pyrilutamide (Kx-826) Cleared By NMPA
Brief: Legend Holdings Cuts Stake In Kintor Pharmaceutical - HKEX Filing
Brief: Kintor Pharmaceutical Says Clinical Trial Of Pd-L1/Tgf-Β Dual-Targeting Antibody (Gt90008) Approved By NMPA
Brief: Kintor Pharmaceutical Announces Clinical Trial Approval Of ALK-1 & Nivolumab Combination Therapy
HK-listed WuXi Biologics leads slide in pharma stocks on Merck COVID-19 pill success
Brief: Zhuhai Gree Group's Long Position In Kintor Pharmaceutical Falls To 6.77% - HKEX Filing
Brief: Kintor Pharmaceutical Expects To Commence Phase III Clinical Trial Of Kx-826 In China In Q4
HK-listed Kintor Pharma jumps on inclusion in Stock Connect program
Brief: Kintor Gets NMPA Approval For Trials Of Proxalutamide To Treat COVID-19 In China
Brief: Kintor Pharmaceutical Posts HY Loss & Total Comprehensive Loss Attributable RMB325.8 Mln
Brief: Kintor Pharmaceutical Entered Licensing Agreement With Pt Etana Biotechnologies Indonesia